06-Jul-2022 | Zion Market Research
The global minimally invasive neurosurgery device market was worth around $2711 million in 2021 and is predicted to grow to around $4000 million by 2028 at a CAGR rate of 4.1% over the forecast period.
Minimally invasive neurosurgery is done through a small incision in the body part to perform surgeries on the brain, skull base, or spinal cord. This surgical procedure is much better and more efficient than conventional surgical procedures. This reduces the recovery period to a minimum and is more efficient for older patients.
Minimally invasive surgery procedures fix the defective parts through a small hole with much more image clarity and clearer anatomical structures. Even the minor issues in tissues and cells can be cured and fixed to precision. The accuracy rate in this method is more promising than conventional surgical procedures and is a safer option for the patients. There is also a lesser loss of blood or any possibility of casualties while the surgery is performed.
Covid-19 has had a neutral and modest impact on the minimally invasive neurosurgery device market. All healthcare facilities and equipment were reserved for Covid-19 patients and other illnesses were discarded. Neurosurgeons abstained from performing any surgeries or even attending any operations due to the fear of getting infected. Manufacturing of these devices was stalled due to curfews and lockdown which brought down the supply and demand of the products. At the same time, all healthcare firms were swamped with lots of patients and more importance was given to emergency surgeries. This boosted the demand for these devices to some extent and the global minimally invasive neurosurgery device market is expected to grow in the coming years with the emergence of vaccinations and herd immunizations.
The frequent increase in medical research with respect to neurological sectors propels market growth. There is also a considerable rise in the geriatric population across the world who would benefit more from these minimally invasive neurosurgery procedures. Neurological disorders among people have become more expansive and prominent which hikes up the demand for this treatment method.
Lots of innovation programs and research analyses in the field of neurology are on the rise which bolsters market expansion. Augmented reality and AI technology are slowly integrated into these minimally invasive procedures which are in the favor of many physicians and patients simultaneously.
The easy recovery option and faster healing after the surgery make it a more leveraged treatment method. Many people opt for minimally invasive neurosurgery procedures than conventional surgical procedures.
On the other hand, the shortage of skilled professionals in the field of minimally invasive neurosurgery procedures and the complexity of the instruments involved in this treatment method hamper the market growth. The high cost associated with the devices of these minimally invasive neurosurgery methods also restricts the demand for these treatment procedures to a large extent.
The global minimally invasive neurosurgery device market is fragmented into products, surgery types, end-users, and regions. The products are classified into handheld devices, inflation devices, surgical devices, and endoscopy devices. The surgery types are divided into urological, vascular, cardiac, cosmetic, and orthopedic. End users are hospitals and ASCs
North America leads as the major contributor to the global minimally invasive neurosurgery device market due to the increasing number of neurological disorder cases. There is an ample number of innovation programs and technological advancements in the neurology field which amplifies market expansion in this region. The modernization of healthcare infrastructures and government initiatives to support efficient treatment procedures boost the market growth in the Asia-Pacific region. Manufacturers integrate AI techniques in the treatment procedures to ease the performance of the devices. This factor propels market expansion in this region to a large extent.
Major players in the global minimally invasive neurosurgery device market are Karl Storz GmbH & Co. KG, Olympus Corporation, Conmed Corporation, Richard Wolf GmbH, Boston Scientific Inc., Integra Lifescience Holdings Corporation, Aesculap Division, Smith & Nephew Plc, Medtronic, NICO Corp.
Browse the full “Minimally Invasive Neurosurgery Device Market By Product (Handheld Devices, Inflation Devices, Surgical Devices, And Endoscopy Devices), By Surgery Type (Urological, Vascular, Cardiac, Cosmetic, And Orthopedic), By End-Users (Hospitals And ASCs), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/minimally-invasive-neurosurgery-devices-market
The global minimally invasive neurosurgery device market is segmented as
By Surgery Types
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651